12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant price movements. Healthcare Triangle, Mira Pharmaceuticals, MEI Pharma, TuHURA Biosciences, P3 Health Partners, and OKYO Pharma saw notable gains, while Aclaris Therapeutics, Beyond Air, Qualigen Therapeutics, Nuwellis, Compass Pathways, and Helius Medical Tech experienced declines.
October 25, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Healthcare Triangle shares surged by 62.3% to $0.94, significantly increasing its market cap to $5.3 million.
The substantial increase in HCTI's share price indicates strong investor interest or positive news, likely leading to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
TuHURA Biosciences shares moved up by 16.05% to $5.35, with a market cap of $224.6 million.
The increase in HURA's stock price suggests positive developments or investor interest, likely leading to further gains.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
MEI Pharma shares increased by 22.54% to $3.37, with a market cap of $22.4 million.
The rise in MEIP's stock price indicates positive investor sentiment, which may continue in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Mira Pharmaceuticals shares rose 23.25% to $1.59, with a market cap of $23.5 million.
The significant rise in MIRA's stock price suggests positive sentiment or news, potentially leading to continued upward momentum.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
OKYO Pharma stock rose 9.52% to $1.38, with a market cap of $46.6 million.
The increase in OKYO's stock price suggests positive investor sentiment, potentially leading to further gains.
CONFIDENCE 75
IMPORTANCE 55
RELEVANCE 100
POSITIVE IMPACT
P3 Health Partners stock increased by 15.24% to $0.47, with a market cap of $75.7 million.
The rise in PIII's stock price indicates positive sentiment, which may continue to drive the stock higher in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Aclaris Therapeutics shares declined by 9.5% to $1.53, with a market cap of $109.1 million.
The decline in ACRS's stock price indicates negative sentiment or news, likely leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Compass Pathways stock fell 6.69% to $5.86, with a market cap of $400.7 million.
The decline in CMPS's stock price indicates negative sentiment, likely leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Helius Medical Tech stock fell 6.44% to $0.46, with a market cap of $1.6 million.
The decrease in HSDT's stock price suggests negative sentiment, which may continue to impact the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Nuwellis stock fell 6.92% to $1.73, with a market cap of $3.2 million.
The decrease in NUWE's stock price suggests negative sentiment, which may continue to impact the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Qualigen Therapeutics stock decreased by 6.92% to $0.11, with a market cap of $3.0 million.
The decline in QLGN's stock price indicates negative sentiment, likely leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Beyond Air stock declined by 6.95% to $0.37, with a market cap of $26.7 million.
The decrease in XAIR's stock price suggests negative sentiment, which may continue to impact the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100